CAMBRIDGE, Mass., Jan. 11, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the company has an updated presentation time at the 28th Annual J.P. Morgan Healthcare Conference. Adelene Q. Perkins, President and Chief Executive Officer, will present a company overview on Tuesday, January 12, 2010 at 3:00 p.m. PST at the Westin St. Francis Hotel in San Francisco, Calif.
A live webcast of Infinity's presentation will be accessible on the company's website at http://www.infi.com and will be archived on the website for 30 days.
About Infinity Pharmaceuticals, Inc. Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway and fatty acid amide hydrolase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.